Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial
Elisa Pose, Laura Napoleone, Ahmed Amin, Daniela Campion, César Jimenez, Salvatore Piano, Olivier Roux, Frank Erhard Uschner, Koos de Wit, Giacomo Zaccherini, Carlo Alessandria, Paolo Angeli, Mauro Bernardi, Ulrich Beuers, Paolo Caraceni, François Durand, Rajeshwar P. Mookerjee, Jonel Trebicka, Victor Vargas, Raúl J. AndradeMarta Carol, Judit Pich, Juan Ferrero, Gema Domenech, Marta Llopis, Ferran Torres, Patrick S. Kamath, Juan G. Abraldes, Elsa Solà, Pere Ginès
Dive into the research topics of 'Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial'. Together they form a unique fingerprint.